R&D Facility Consolidation:

The Client

The client is a leading pharmaceutical company that develops vaccines and medicines to treat an array of illnesses and medical conditions. The company is consistently ranked among the top 10 pharmaceutical companies on the planet and has facilities worldwide.

The Challenge

Our client was in the process of consolidating its R&D facility in Europe and determined that the majority of equipment in its Mont-Saint-Guibert, Belgium facility was surplus to the ongoing operations.

This two-building facility contained a mix of lab and analytical equipment as well as some pilot scale API equipment; all of which needed to be sold and removed in a timely manner in order to successfully complete its consolidation project.

The Solution

Given a tight deadline to complete this disposition project, EquipNet opted to deploy a two-tier sales plan that entailed several months of managed pricing by the Direct Sales Force, and an auction event to complete the clearance of the Belgian facility’s assets.

•Project Management                   • Dedicated Online Auction
•Individual Asset Sales                 • Worldwide Logistics

The Result

By marketing the client’s assets with end-user buyers in mind, EquipNet was able to sell 160 premium assets through the online MarketPlace, and the remaining 150 assets in a webcast auction event. At the project’s end, EquipNet returned more than €2,200,000 in sales proceeds to the client; adhering directly to its provided time frame and going well beyond the client’s expectations.

Number of Assets

Sales Proceeds
€2.2 Million

Equipment Categories
Lab and Analytical Equipment
Pilot Scale API Equipment

Project Management
Individual Asset Sales
Dedicated Online Auction
Worldwide Logistics

Interested in Learning More About Our Services?

Contact Us Today